The incidence of ovarian carcinoma in Poland is 11.2/100,000. It is the second most common cancer of the genital tract. First-line treatment involves surgery and chemotherapy, which leads to adverse effects. They include urinary tract disorders that affect the quality of life. The aim of the study was to compare the function of the urinary tract and quality of life in women after ovarian cancer treatment with women after hysterectomy with salpingo-oophorectomy performed for non-oncological indications. Urodynamic tests and questionnaires were conducted in 40 patients divided into two groups. The investigated group included 17 patients after ovarian cancer therapy in whom complete cytoreduction was obtained in surgery and first-line chemotherapy was administered. The control group consisted of 23 patients after hysterectomy performed for non-oncological indications. In all cases, medical history was collected, pelvic examination and urodynamic test were carried out and a quality of life questionnaire was conducted. The percentage of patients with no changes in the urogynecologic examination was higher among non-oncological patients (65.2%). In cancer patients, no changes were detected in 41.2% of cases. Cancer patients suffered from stress incontinence, mixed urinary incontinence and overactive bladder more frequently than controls. The differences obtained in the urogynecologic examination were not statistically significant (p = 0.4573). It was demonstrated, however, that the quality of life differed between the two groups in a statistically significant way (p = 0.0345). Worse quality of life was seen significantly more frequently in cancer patients (58.8%) than in controls (26.1%). Moreover, the improvement of the quality of life was observed more rarely (11.8% in cancer patients vs. 47.8% in controls). Chemotherapy does not have a significant influence on an increase in the number of urogenital disorders but can be one of the factors responsible for the deterioration of the quality of life.